Changrayil Meditech Private Limited
About Changrayil Meditech Private Limited
Data last updated:
Changrayil Meditech Private Limited is a private limited company based in Perumbillissery, Kerala, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 27 January 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24232KL2016PTC039971. Its GSTIN is 32AAGCC3404K1Z0 (Kerala).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Rajan Easwara Warrier (Managing Director) and Krishnaraj Warrier.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 20/812 Changarayil Warriam, Perumbillissery, Kerala, India – 680561.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.65 Cr, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹6.08 Lakh (net margin 3.7%) and EBITDA of ₹11.58 Lakh (EBITDA margin 7%). Revenue has grown at a compounded annual rate (CAGR) of 35% over three years and 9% over five years.
As per MCA filings, the company has open charges of ₹1 Cr and satisfied charges of ₹63.5 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address20/812 Changarayil Warriam, Perumbillissery, Kerala, India – 680561
- IndustryChemicals and Materials, Industrial Chemicals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Changrayil Meditech Private Limited
The main business activity of Changrayil Meditech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Changrayil Meditech Private Limited FY 2025 filings available
Changrayil Meditech Private Limited reported revenue of ₹1.65 Cr (up 28% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Changrayil Meditech Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 28% growth in the latest year. EBITDA rose 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Changrayil Meditech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹11.58 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹6.08 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Changrayil Meditech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Changrayil Meditech are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Changrayil Meditech Private Limited
Changrayil Meditech Private Limited is compared with the companies closest to it by revenue in the Chemicals industry (Healthcare Equipment Retail and Distribution, Industrial Chemicals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Noburu Chemicals Private Limited | ₹1.65 Cr (FY 2025) | •••• | •••• | -29.0% | •••• | Vadodara, Gujarat, India |
| XCL B2b Services Private Limited | ₹1.65 Cr (FY 2024) | •••• | •••• | 14.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Nikhil Intermediates Pvt Ltd | ₹1.65 Cr (FY 2025) | •••• | •••• | 118.0% | •••• | Ahmedabad, Gujarat, India |
| Crisana Synthetics Private Limited | ₹1.65 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Mumbai, Maharashtra, India |
| Marc Medical Systems Private Limited | ₹1.65 Cr (FY 2025) | •••• | •••• | •••• | Kanpur, Uttar Pradesh, India | |
| Changrayil Meditech Private Limited this company | ₹1.65 Cr (FY 2025) | •••• | •••• | 28.0% | •••• | Perumbillissery, Kerala, India |
| Rising Chemicals Private Limited | ₹1.65 Cr (FY 2025) | •••• | •••• | -34.0% | •••• | Nagpur, Maharashtra, India |
| New Bright Alloychem Private Limited | ₹1.65 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Agra, Uttar Pradesh, India |
| Ashar Chemicals Private Limited | ₹1.64 Cr (FY 2025) | •••• | •••• | -39.0% | •••• | Rajkot, Gujarat, India |
| Micro Hydrochem Private Limited | ₹1.64 Cr (FY 2024) | •••• | •••• | 2.0% | •••• | New Delhi, Delhi, India |
| Mehta Esters Private Limited | ₹1.64 Cr (FY 2024) | •••• | •••• | 101.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Changrayil Meditech by revenue in the Chemicals industry (Healthcare Equipment Retail and Distribution, Industrial Chemicals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Changrayil Meditech Private Limited
Changrayil Meditech Private Limited is audited by G JOSEPH & ASSOCIATES for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| G JOSEPH & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Changrayil Meditech Private Limited
Changrayil Meditech has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krishnaraj Warrier Also directs: Cath Medical Devices Private Limited | Director | 27 Jan 2016 | 10 Years 8 Months | Current |
| Rajan Easwara Warrier | Managing Director | 27 Jan 2016 | 10 Years 8 Months | Current |
Ownership and Shareholding of Changrayil Meditech Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Changrayil Meditech Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Jun 2016 | Others | ₹1 Cr | Open |
| 31 May 2022 | Others | ₹4.5 Lakh | Satisfied |
| 27 Jul 2020 | Others | ₹9 Lakh | Satisfied |
| 17 Jun 2016 | Others | ₹50 Lakh | Satisfied |
Total charge records: 4 View all charges
Employees and EPFO Compliance at Changrayil Meditech Private Limited
Employment history and EPFO contributions of people linked to Changrayil Meditech.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Changrayil Meditech Private Limited
Changrayil Meditech Private Limited has 3 board changes on record since 2016: 3 appointments. The latest: Krishnaraj Warrier was appointed as Director on 27 Jan 2016.
2 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Changrayil Meditech Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Changrayil Meditech Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Changrayil Meditech Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Changrayil Meditech Private Limited
Changrayil Meditech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAGCC3404K1Z0 | Kerala | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Changrayil Meditech Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Changrayil Meditech Private Limited
Changrayil Meditech is an active private limited company based in Perumbillissery, Kerala, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 27 January 2016 (10+ years old) and is registered under CIN U24232KL2016PTC039971.
Changrayil Meditech reported revenue of ₹1.65 Cr for FY 2025 (up 28% YoY).
Changrayil Meditech has 2 current directors:
- Rajan Easwara Warrier - Managing Director
- Krishnaraj Warrier - Director
Changrayil Meditech reported a net profit of ₹6.08 Lakh (net margin 3.7%) and EBITDA of ₹11.58 Lakh (EBITDA margin 7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Changrayil Meditech is 35% over three years and 9% over five years. In the latest year (FY 2025) revenue rose 28%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Changrayil Meditech is 32AAGCC3404K1Z0, registered in Kerala.
The CIN (Corporate Identification Number) of Changrayil Meditech is U24232KL2016PTC039971. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Changrayil Meditech was incorporated on 27 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Changrayil Meditech by revenue are Noburu Chemicals Private Limited, XCL B2b Services Private Limited, Nikhil Intermediates Pvt Ltd, Crisana Synthetics Private Limited, Marc Medical Systems Private Limited and 5 more, all in the Chemicals industry (Healthcare Equipment Retail and Distribution, Industrial Chemicals).
Krishnaraj Warrier was appointed as Director on 27 Jan 2016. Rajan Easwara Warrier was appointed as Managing Director on 27 Jan 2016. Sankarankutty Satish was appointed as Director on 27 Jan 2016.
The registered office of Changrayil Meditech is at 20812 Changarayil Warriam, Perumbillissery, Kerala, India – 680561.